Tag: RBS

Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

RBS` recovery is on track, but its exposure to Ireland will continue to mean heavy loan losses.

Morningstar’s credit rating of BBB+ for Royal Bank of Scotland reflects the bank’s large balance of nonperforming loans but is bolstered by the recent improvements in the bank’s operating performance. Through acquisitions, Royal Bank of Scotland has become a global bank, with operations in 50 countries. RBS is primarily a business bank and is dominated by its global banking and markets division, which has historically … Continue reading RBS` recovery is on track, but its exposure to Ireland will continue to mean heavy loan losses.

John MeadyLeave a comment
Finance

Market Movers – IAMGOLD (NYSE:IAG) , Goldcorp (NYSE:GG) , Royal Bank of Scotland (NYSE:RBS) , IPCC, BBVA Banco (NYSE:BFR)

IAMGOLD Corp (USA) (NYSE:IAG) will release its second quarter 2014 financial results after market hours on Wednesday, August 13th, 2014. IAMGOLD Corp (USA) (NYSE:IAG) stock performance was -0.77% in last session and finished the day at $3.88. Traded volume was 6.65million shares in the last session and the average volume of the stock remained 5.92million shares. The beta of the stock remained 0.49. Goldcorp Inc. … Continue reading Market Movers – IAMGOLD (NYSE:IAG) , Goldcorp (NYSE:GG) , Royal Bank of Scotland (NYSE:RBS) , IPCC, BBVA Banco (NYSE:BFR)

Kevin Long
Finance

Stocks Getting Investor’s Attention: Arena Pharmaceuticals (NASDAQ:ARNA), Oasis Petroleum (NYSE:OAS), The Royal Bank of Scotland (NYSE:RBS), WisdomTree Investments (NASDAQ:WETF), BPT

On Jan 08, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced encouraging top-line results from a phase Ib study (n=50) on APD334 being developed for the treatment of autoimmune diseases. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is 51.25%. On last trading day company shares ended up $5.43. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is 31.40%. Hedge fund SPO … Continue reading Stocks Getting Investor’s Attention: Arena Pharmaceuticals (NASDAQ:ARNA), Oasis Petroleum (NYSE:OAS), The Royal Bank of Scotland (NYSE:RBS), WisdomTree Investments (NASDAQ:WETF), BPT

Chris Lewis